Cargando…
Dehydroabietic Acid Is a Novel Survivin Inhibitor for Gastric Cancer
Gastric cancer is a malignant tumor with a high incidence and mortality rate worldwide. Nevertheless, anticancer drugs that can be used for gastric cancer treatment are limited. Therefore, it is important to develop targeted anticancer drugs for the treatment of gastric cancer. Dehydroabietic acid (...
Autores principales: | Kim, Won-Jin, Kim, Woong, Bae, Jang-Mi, Gim, Jungsoo, Kim, Seok-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224772/ https://www.ncbi.nlm.nih.gov/pubmed/34067279 http://dx.doi.org/10.3390/plants10061047 |
Ejemplares similares
-
Dehydroabietic acid
por: Rao, Xiao-Ping, et al.
Publicado: (2009) -
Synthesis and Antiproliferative Activity of Novel Dehydroabietic Acid-Chalcone Hybrids
por: Grigoropoulou, Sophia, et al.
Publicado: (2022) -
Synthesis and biological evaluation of 2-aryl-benzimidazole derivatives of dehydroabietic acid as novel tubulin polymerization inhibitors
por: Miao, Ting-Ting, et al.
Publicado: (2018) -
Synthesis and In Vitro Anticancer Activity of Novel Dehydroabietic Acid-Based Acylhydrazones
por: Li, Fang-Yao, et al.
Publicado: (2017) -
The conifer biomarkers dehydroabietic and abietic acids are widespread in Cyanobacteria
por: Costa, Maria Sofia, et al.
Publicado: (2016)